The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome
Open accessAbstract
Dravet syndrome is a severe epilepsy syndrome characterized by infantile onset of therapy-resistant, fever-sensitive seizures followed by cognitive decline. Mutations in SCN1A explain about 75% of cases with Dravet syndrome; 90% of these mutations arise de novo. We studied a cohort of nine Dravet-syndrome-affected individuals without an SCN1A mutation (these included some atypical cases with onset at up to 2 years of age) by using whole-exome sequencing in proband-parent trios. In two individuals, we identified a de novo loss-of-function mutation in CHD2 (encoding chromodomain helicase DNA binding protein 2). A third CHD2 mutation was identified in an epileptic proband of a second (stage 2) cohort. All three individuals with a CHD2 mutation had intellectual disability and fever-sensitive generalized seizures, as well as prominent myoclonic seizures starting in the second year of life or later. To explore the functional relevance of CHD2 haploinsufficiency in an in vivo model system, we knocked down chd2 in zebrafish by using targeted morpholino antisense oligomers. chd2-knockdown larvae exhibited altered locomotor activity, and the epileptic nature of this seizure-like behavior was confirmed by field-potential recordings that revealed epileptiform discharges similar to seizures in affected persons. Both altered locomotor activity and epileptiform discharges were absent in appropriate control larvae. Our study provides evidence that de novo loss-of-function mutations in CHD2 are a cause of epileptic encephalopathy with generalized seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in CHD2 have been detected in individuals with a diagnosis of ASD (22), ID (73) or epilepsy (82,83,87,89)”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,485
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome
Vissers, L. E. L. M., van Ravenswaaij‐Arts, C. M. A., Admiraal, R. J. C., Hurst, J. A., Vries, B. B. A. D., Janssen, I. M., van der Vliet, W. A., Huys, E., de Jong, P. J., Hamel, B. C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1407 · Cited by 1,281
Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders
O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. (2012) · Science · doi:10.1126/science.1227764 · Cited by 1,240
Cited by
Sorted by citations
The Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N., Engelstad, M., Foster, E. D., McMurry, J. A., Aymé, S., Baynam, G. S., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 767
Self-citationWang, J., Lin, Z.-J., Liu, L., Xu, H., Shi, Y., Yi, Y., He, N., & Liao, W. (2016) · Seizure · doi:10.1016/j.seizure.2016.11.030 · Cited by 488
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
EuroEPINOMICS, R. E. S., Syrbe, S., Hedrich, U. B. S., Riesch, E., Djémié, T., Müller, S., Møller, R. S., Maher, B. H., Hernández-Hernández, L., Synofzik, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3239 · Cited by 283
Self-citationGenetic Control of Expression and Splicing in Developing Human Brain Informs Disease Mechanisms
Walker, R. L., Ramaswami, G., Hartl, C., Mancuso, N., Gandal, M. J., de la Torre-Ubieta, L., Paşaniuc, B., Stein, J. L., & Geschwind, D. H. (2019) · Cell · doi:10.1016/j.cell.2019.09.021 · Cited by 262
GABRA1 and STXBP1 : Novel genetic causes of Dravet syndrome
Carvill, G. L., Weckhuysen, S., McMahon, J. M., Hartmann, C., Møller, R. S., Hjalgrim, H., Cook, J., Geraghty, E., O’Roak, B. J., Petrou, S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000291 · Cited by 262
Self-citationAnimal models in epilepsy research: legacies and new directions
Grone, B. P., & Baraban, S. C. (2015) · Nature Neuroscience · doi:10.1038/nn.3934 · Cited by 277
Advancing epilepsy genetics in the genomic era
Myers, C. T., & Mefford, H. C. (2015) · Genome Medicine · doi:10.1186/s13073-015-0214-7 · Cited by 253
De novo mutations in HCN1 cause early infantile epileptic encephalopathy
Nava, C., Dalle, C., Rastetter, A., Striano, P., de Kovel, C. G. F., Nabbout, R., Cancés, C., Ville, D. M., Brilstra, E. H., Gobbi, G., et al. (2014) · Nature Genetics · doi:10.1038/ng.2952 · Cited by 232
Self-citationGenetics and genomics of autism spectrum disorder: embracing complexity
De Rubeis, S., & Buxbaum, J. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv273 · Cited by 208
From genotype to phenotype in Dravet disease
Gataullina, S., & Dulac, O. (2016) · Seizure · doi:10.1016/j.seizure.2016.10.014 · Cited by 179
Dravet syndrome and its mimics: Beyond SCN 1A
Steel, D., Symonds, J. D., Zuberi, S. M., & Brunklaus, A. (2017) · Epilepsia · doi:10.1111/epi.13889 · Cited by 179
Next Generation Sequencing and the Future of Genetic Diagnosis
Lohmann, K., & Klein, C. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0288-8 · Cited by 170
Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future
Sakai, C., Ijaz, S., & Hoffman, E. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00294 · Cited by 172
Genetics of structural and functional brain changes in autism spectrum disorder
Hashem, S., Nisar, S., Bhat, A. A., Yadav, S. K., Azeem, M. W., Bagga, P., Fakhro, K. A., Reddy, R. D., Frenneaux, M. P., & Haris, M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00921-3 · Cited by 167
CHD2variants are a risk factor for photosensitivity in epilepsy
Galizia, E. C., Myers, C. T., Leu, C., de Kovel, C. G. F., Afrikanova, T., Cordero-Maldonado, M. L., Martins, T. G., Jacmin, M., Drury, S., Chinthapalli, K., et al. (2015) · Brain · doi:10.1093/brain/awv052 · Cited by 142
Self-citationPharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
Sourbron, J., Smolders, I. J., de Witte, P. A. M., & Lagae, L. G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00191 · Cited by 142
Dravet Syndrome: Diagnosis and Long-Term Course
Connolly, M. B. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.243 · Cited by 126
Bayat, A., Hjalgrim, H., & Møller, R. S. (2015) · Epilepsia · doi:10.1111/epi.12927 · Cited by 120
Self-citationHelbig, I., López-Hernández, T., Shor, O., Galer, P. D., Ganesan, S., Pendziwiat, M., Rademacher, A., Ellis, C. A., Hümpfer, N., Schwarz, N., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.04.001 · Cited by 119
Self-citationUnderstanding Genotypes and Phenotypes in Epileptic Encephalopathies
Helbig, I., & Tayoun, A. N. A. (2016) · Molecular Syndromology · doi:10.1159/000448530 · Cited by 117
Self-citationAndrade, D. M., Bassett, A. S., Bercovici, E., Borlot, F., Bui, E., CAMFIELD, P. R., Clozza, G. Q., Cohen, E., Gofine, T., Graves, L. E., et al. (2017) · Epilepsia · doi:10.1111/epi.13832 · Cited by 114
Seizing the moment: Zebrafish epilepsy models
Gaweł, K., Langlois, M., Martins, T., van der Ent, W., Tiraboschi, E., Jacmin, M., Crawford, A. D., & Esguerra, C. V. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.010 · Cited by 114
Self-citationFunction Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish
Kozol, R. A., Abrams, A. J., James, D. M., Buglo, E., Yan, Q., & Dallman, J. E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00055 · Cited by 116
Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model
Sourbron, J., Schneider, H., Kecskés, A., Liu, Y., Buening, E., Lagae, L. G., Smolders, I. J., & de Witte, P. A. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00342 · Cited by 113
Self-citationCHD2 myoclonic encephalopathy is frequently associated with self-induced seizures
Thomas, R. H., Zhang, L. M., Carvill, G. L., Archer, J. S., Heavin, S. B., Mandelstam, S. A., Craiu, D., Berkovic, S. F., Gill, D. S., Mefford, H. C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001305 · Cited by 100
Self-citationVögtle, F. ‐., Brändl, B., Larson, A. A., Pendziwiat, M., Friederich, M. W., White, S. M., Basinger, A., Küçükköse, C., Muhle, H., Jähn, J. A., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.02.014 · Cited by 98
Self-citationThe role of genetic testing in epilepsy diagnosis and management
Weber, Y., Biskup, S., Helbig, K., von Spiczak, S., & Lerche, H. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1335598 · Cited by 87
Self-citationChénier, S., Yoon, G., Argiropoulos, B., Lauzon, J. L., Laframboise, R., Ahn, J. W., Ogilvie, C. M., Lionel, A. C., Marshall, C. R., Vaags, A. K., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-9 · Cited by 99
Hardies, K., Cai, Y., Jardel, C., Jansen, A., Cao, M., May, P., Djémié, T., Camus, C. H. L., Keymolen, K., Deconinck, T., et al. (2016) · Brain · doi:10.1093/brain/aww180 · Cited by 90
Self-citationThe contribution of next generation sequencing to epilepsy genetics
Møller, R. S., Dahl, H. A., & Helbig, I. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1113132 · Cited by 88
Self-citationTDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling
Berson, A., Sartoris, A., Nativio, R., Deerlin, V. M. V., Toledo, J. B., Porta, S., Liu, S., Chung, C., Garcia, B. A., Lee, V. M. ‐., et al. (2017) · Current Biology · doi:10.1016/j.cub.2017.10.024 · Cited by 90
Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
Schoonjans, A., Lagae, L. G., & Ceulemans, B. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615607726 · Cited by 82
The Problem of Rarity: Estimation of Prevalence in Rare Disease
Auvin, S., Irwin, J., Abi-Aad, P., & Battersby, A. (2018) · Value in Health · doi:10.1016/j.jval.2018.03.002 · Cited by 85
Aras, L. M., Isla, J., & Mingorance, A. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.12.028 · Cited by 80
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures
Myers, C. T., Stong, N., Mountier, E. I., Helbig, K. L., Freytag, S., Sullivan, J. E., Zeev, B. B., Nissenkorn, A., Tzadok, M., Heimer, G., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.08.013 · Cited by 72
Dougnon, G., & Matsui, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147550 · Cited by 76
Genetics of reflex seizures and epilepsies in humans and animals
Italiano, D., Striano, P., Russo, E., Leo, A., Spina, E., Zara, F., Striano, S., Gambardella, A., Labate, A., Gasparini, S., et al. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.01.010 · Cited by 73
Self-citationEpigenetic genes and epilepsy — emerging mechanisms and clinical applications
Van Loo, K. M. J., Carvill, G. L., Becker, A. J., Conboy, K., Goldman, A. M., Kobow, K., Lopes-Cendes, I., Reid, C. A., van Vliet, E. A., & Henshall, D. C. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00693-y · Cited by 68
Chromatin Remodeling Proteins in Epilepsy: Lessons From CHD2-Associated Epilepsy
Lamar, K., & Carvill, G. L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00208 · Cited by 69
De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy
Lange, I., Helbig, K. L., Weckhuysen, S., Møller, R. S., Velinov, M. T., Dolzhanskaya, N., Marsh, E. D., Helbig, I., Devinsky, O., Tang, S., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103909 · Cited by 66
Self-citationMutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia
Rodrı́guez, D., Bretones, G., Quesada, V., Villamor, N., Arango, J. R., López‐Guillermo, A., Ramsay, A. J., Baumann, T., Quirós, P. M., Navarro, A., et al. (2015) · Blood · doi:10.1182/blood-2014-10-604959 · Cited by 67
CHD2 mutations in Lennox–Gastaut syndrome
Lund, C., Brodtkorb, E., Øye, A.-M., Røsby, O., & Selmer, K. K. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.02.005 · Cited by 64
Self-citationPast, present and future of zebrafish in epilepsy research
Yaksi, E., Jamali, A., Verdugo, C. D., & Jurisch‐Yaksi, N. (2021) · FEBS Journal · doi:10.1111/febs.15694 · Cited by 64
Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and diseasePreprint
Alendar, A., & Berns, A. J. M. (2021) · Genes & Development · doi:10.1101/gad.348897.121 · Cited by 69
Evaluating the pathogenic potential of genes with de novo variants in epileptic encephalopathies
He, N., Lin, Z.-J., Wang, J., Wei, F., Meng, H., Liu, X., Chen, Q., Su, T., Shi, Y., Yi, Y., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0011-y · Cited by 59
Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures
Tang, S. S., Addis, L., Smith, A. B., Topp, S. D., Pendziwiat, M., Mei, D., Parker, A. P. J., Agrawal, S., Hughes, E., Lascelles, K., et al. (2020) · Epilepsia · doi:10.1111/epi.16508 · Cited by 61
Self-citationDu, X., An, Y., Yu, L., Liu, R., Qin, Y., Guo, X., Sun, D., Zhou, S., Wu, B.-L., Jiang, Y., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-62 · Cited by 57
Genetic therapeutic advancements for Dravet Syndrome
Chilcott, E. M., Diaz, J. F. A., Bertram, C., Berti, M., & Karda, R. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108741 · Cited by 59
The 16p11.2 homologs fam57ba and doc2a generate certain brain and body phenotypes
McCammon, J. M., Blaker, A. L., Chen, X., & Sive, H. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx255 · Cited by 57
Guerrini, R., Marini, C., & Mantegazza, M. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0267-0 · Cited by 57
Self-citationChromodomain Helicase DNA-Binding Proteins in Stem Cells and Human Developmental Diseases
Micucci, J. A., Sperry, E. D., & Martin, D. M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0544 · Cited by 56
d’Amora, M., Galgani, A., Marchese, M., Tantussi, F., Faraguna, U., Angelis, F. D., & Giorgi, F. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097702 · Cited by 57
Imaging epilepsy in larval zebrafish
Burrows, D. R. W., Samarut, É., Liu, J., Baraban, S. C., Richardson, M. P., Meyer, M. P., & Rosch, R. E. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.01.006 · Cited by 60
Autism spectrum disorder and epileptic encephalopathy: common causes, many questions
Srivastava, S., & Şahin, M. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9202-0 · Cited by 55
From next-generation sequencing to targeted treatment of non-acquired epilepsies
Møller, R. S., Hammer, T. B., Rubboli, G., Lemke, J. R., & Johannesen, K. M. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1573144 · Cited by 53
Self-citationHengel, H., Bosso-Lefèvre, C., Grady, G., Szenker‐Ravi, E., Li, H., Pierce, S. B., Lebigot, É., Tan, T. T., Eio, M. Y., Narayanan, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14360-7 · Cited by 54
Self-citationHuman CHD2 Is a Chromatin Assembly ATPase Regulated by Its Chromo- and DNA-binding Domains
Liu, J. C., Ferreira, C. G., & Yusufzai, T. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609156 · Cited by 52
Depdc5 knockdown causes mTOR ‐dependent motor hyperactivity in zebrafish
de Calbiac, H., Nagy-Dăbâcan, A., Marsan, E., Tostivint, H., Devienne, G. F., Ishida, S., Leguern, É., Baulac, S., Muresan, R. C., Kabashi, E., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.542 · Cited by 59
Self-citationEpigenetic mechanisms in epilepsy
Kobow, K., & Blümcke, I. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00014-4 · Cited by 57
Identification of GSK-3 as a potential therapeutic entry point for epilepsy.
Aourz, N., Serruys, A.-S. K., Chabwine, J. N., Balegamire, P. B., Afrikanova, T., Edrada-Ebel, R., Grey, A. I., Kamuhabwa, A. R., Walrave, L., Esguerra, C. V., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00281 · Cited by 49
Self-citationModels for discovery of targeted therapy in genetic epileptic encephalopathies
Maljevic, S., Reid, C. A., & Petrou, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14134 · Cited by 46
Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features
Niturad, C. E., Lev, D., Kalscheuer, V. M., Charzewska, A., Schubert, J., Lerman‐Sagie, T., Kroes, H. Y., Oegema, R., Traverso, M., Specchio, N., et al. (2017) · Brain · doi:10.1093/brain/awx236 · Cited by 47
Self-citationCunliffe, V. T. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.07.015 · Cited by 46
Li, W., & Mills, A. A. (2014) · Epigenomics · doi:10.2217/epi.14.31 · Cited by 46
Leclercq, K., Afrikanova, T., Langlois, M., Prins, A. D., Buenafe, O. E. M., Rospo, C. C., Eeckhaut, A. V., de Witte, P. A. M., Crawford, A. D., Smolders, I. J., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.03.019 · Cited by 45
Self-citationEpigenetic principles underlying epileptogenesis and epilepsy syndromes
Conboy, K., Henshall, D. C., & Brennan, G. P. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105179 · Cited by 46
Gaweł, K., Turski, W. A., van der Ent, W., Mathai, B. J., Kirstein-Smardzewska, K. J., Simonsen, A., & Esguerra, C. V. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01860-x · Cited by 45
Self-citationWang, J., Wen, Y., Zhang, Q., Yu, S., Chen, Y., Wu, X., Zhang, Y., & Bao, X. (2019) · Seizure · doi:10.1016/j.seizure.2019.01.025 · Cited by 42
Galer, P. D., Ganesan, S., Lewis‐Smith, D., Ruggiero, S. M., Pendziwiat, M., Helbig, K. L., Ellis, C. A., Rademacher, A., Smith, L. A., Poduri, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.08.003 · Cited by 38
Self-citationPCDH19‐related epileptic encephalopathy in a male mosaic for a truncating variant
Thiffault, I., Farrow, E., Smith, L. D., Lowry, J. A., Zellmer, L., Black, B. T., Abdelmoity, A. T., Miller, N., Soden, S. E., & Saunders, C. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37617 · Cited by 39
CHD2 mutations are a rare cause of generalized epilepsy with myoclonic–atonic seizures
Trivisano, M., Striano, P., Sartorelli, J., Giordano, L., Traverso, M., Accorsi, P., Cappelletti, S., Claps, D., Vigevano, F., Zara, F., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.06.029 · Cited by 39
Self-citationParenti, I., Lehalle, D., Nava, C., Torti, E. E., Leitão, E., Person, R., Mizuguchi, T., Matsumoto, N., Kato, M., Nakamura, K., et al. (2021) · Human Genetics · doi:10.1007/s00439-021-02283-2 · Cited by 38
Self-citationTherapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy
Agbo, J., Ibrahim, Z. G., Magaji, S. Y., Mutalub, Y. B., Mshelia, P. P., & Mhya, D. H. (2023) · Acta Epileptologica · doi:10.1186/s42494-023-00127-2 · Cited by 37
CHD2‐related epilepsy: novel mutations and new phenotypes
Chen, J., Zhang, J., Liu, A., Zhang, L., Li, H., Zeng, Q., Yang, Z., Yang, X., Wu, X., & Zhang, Y. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14367 · Cited by 39
Duszyc, K., Terczyńska, I., & Hoffman‐Zacharska, D. (2014) · Journal of Applied Genetics · doi:10.1007/s13353-014-0243-8 · Cited by 35
Self-citationSantos-Fandila, A., Vázquez, E., Barranco, A., Zafra‐Gómez, A., Navalón, A., Rueda, R., & Ramírez, M. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.07.040 · Cited by 34
Wilson, M., Henshall, D. C., Byrne, S. M., & Brennan, G. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020588 · Cited by 36
Law, C. Y., Chang, S. T.-L., Cho, S. Y., Yau, E. K., Ng, G. S. F., Fong, N.-C., & Lam, C. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.011 · Cited by 31
Zebrafish Models of Epilepsy and Epileptic Seizures
Copmans, D., Siekierska, A., & de Witte, P. A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00026-2 · Cited by 31
Self-citationKobow, K., Reid, C. A., van Vliet, E. A., Becker, A. J., Carvill, G. L., Goldman, A. M., Hirose, S., Lopes‐Cendes, Í., Khiari, H. M., Poduri, A., et al. (2020) · Epileptic Disorders · doi:10.1684/epd.2020.1143 · Cited by 31
Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
Pensado‐López, A., Veiga-Rúa, S., Carracedo, Á., Allegue, C., & Sanchez, L. E. (2020) · Genes · doi:10.3390/genes11111376 · Cited by 34
Maria, B. D., Balestrini, S., Mei, D., Melani, F., Pellacani, S., Pisano, T., Rosati, A., Scaturro, G. M., Giordano, L., Cantalupo, G., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62548 · Cited by 30
Self-citationLiu, C., Kang, N., Guo, Y., & Gong, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.710203 · Cited by 29
Pleiotropy of autism-associated chromatin regulators
Lasser, M. C., Sun, N., Xu, Y., Wang, S., Drake, S., Law, K., Gonzalez, S., Wang, B., Drury, V., Castillo, O., et al. (2023) · Development · doi:10.1242/dev.201515 · Cited by 31
Epileptic Encephalopathies—Clinical Syndromes and Pathophysiological Concepts
von Deimling, M., Helbig, I., & Marsh, E. D. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0720-7 · Cited by 30
Self-citationReprogramming of the epigenome in neurodevelopmental disorders
Wilson, K., Porter, E. G. P., & Garcia, B. A. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1979457 · Cited by 27
Lessons learned from gene identification studies in Mendelian epilepsy disorders
Hardies, K., Weckhuysen, S., Jonghe, P. D., & Suls, A. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.251 · Cited by 26
Self-citationGenetics and gene therapy in Dravet syndrome
Higurashi, N., Broccoli, V., & Hirose, S. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108043 · Cited by 26
Autism‐linked CHD gene expression patterns during development predict multi‐organ disease phenotypes
Kasah, S., Oddy, C., & Basson, M. A. (2018) · Journal of Anatomy · doi:10.1111/joa.12889 · Cited by 25
Courage, C., Houge, G., Gallati, S., Schjelderup, J., & Rieubland, C. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.06.003 · Cited by 24
Genetic basis of pediatric epilepsy syndromes
Zhang, D., Liu, X., & Deng, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4267 · Cited by 25
Sex, epilepsy, and epigenetics
Qureshi, I., & Mehler, M. F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.019 · Cited by 24
The NuRD complex in neurodevelopment and disease: a case of sliding doors
Boulasiki, P., Tan, X. W., Spinelli, M., & Riccio, A. (2023) · Cells · doi:10.3390/cells12081179 · Cited by 22
Network for Therapy in Rare Epilepsies (NETRE): Lessons From the Past 15 Years
von Stülpnagel, C., van Baalen, A., Borggraefe, I., Eschermann, K., Hartlieb, T., Kiwull, L., Pringsheim, M., Wolff, M., Kudernatsch, M., Wiegand, G., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.622510 · Cited by 21
Self-citationEpilepsy: Old Syndromes, New Genes
Weckhuysen, S., & Korff, C. M. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0447-7 · Cited by 21
Self-citationChromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue
Janowski, M., Milewska, M., Zare, P., & Pękowska, A. (2021) · Pharmaceuticals · doi:10.3390/ph14080765 · Cited by 21
Zebrafish models of candidate human epilepsy-associated genes provide evidence of hyperexcitability
LaCoursiere, C. M., Ullmann, J. F. P., Koh, H. Y., Turner, L. H., Baker, C. M., Robens, B. K., Shao, W., Rotenberg, A., McGraw, C. M., & Poduri, A. (2024) · iScience · doi:10.1016/j.isci.2024.110172 · Cited by 20
Genetic investigations of the epileptic encephalopathies
Myers, C. T., & Mefford, H. C. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.04.006 · Cited by 22
Petersen, A. K., Streff, H. E., Tokita, M., & Bostwick, B. L. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38835 · Cited by 21
De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies
Manivannan, S., Roovers, J., Smal, N., Myers, C. T., Türkdoğan, D., Roelens, F., Kanca, O., Chung, H.-L., Scholz, T., Hermann, K., et al. (2021) · Brain · doi:10.1093/brain/awab409 · Cited by 19
Self-citation
Metadata
- Authors
- Suls, A., Jaehn, J. A., Kecskés, A., Weber, Y., Weckhuysen, S., Craiu, D. C., Siekierska, A., Djémié, T., Afrikanova, T., Gormley, P., von Spiczak, S., Kluger, G., Iliescu, C. M., Talvik, T., Talvik, I., Meral, C., Caglayan, H. S., Giraldez, B. G., Serratosa, J., Lemke, J. R., Hoffman-Zacharska, D., Szczepanik, E., Barisic, N., Komarek, V., Hjalgrim, H., Møller, R. S., Linnankivi, T., Dimova, P., Striano, P., Zara, F., Marini, C., Guerrini, R., Depienne, C., Baulac, S., Kuhlenbäumer, G., Crawford, A. D., Lehesjoki, A.-E., de Witte, P. A. M., Palotie, A., Lerche, H., Esguerra, C. V., De Jonghe, P., Helbig, I., Hendrickx, R., Holmgren, P., Stephani, U., Muhle, H., Pendiziwiat, M., Appenzeller, S., Selmer, K., Brilstra, E., Koeleman, B., Rosenow, F., Leguern, E., Sterbova, K., Magdalena, B., Rodica, G., Arsene, O. T., Diana, B., Guerrero-Lopez, R., Ortega, L., Todorova, A. P., Kirov, A. V., Robbiano, A., Arslan, M., Yiş, U., & Ivanović, V.
- Affiliations
- University of Antwerp (BE)
- Hertie Institute for Clinical Brain Research (DE)
- Carol Davila University of Medicine and Pharmacy (RO)
- KU Leuven (BE)
- Wellcome Sanger Institute (GB)
- Schön Klinik Vogtareuth (DE)
- Tartu University Hospital (EE)
- GATA Haydarpaşa Eğitim Hastanesi (TR)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- University Hospital of Bern (CH)
- University of Southern Denmark (DK)
- University of Helsinki (FI)
- Istituto Giannina Gaslini (IT)
- Meyer Children's Hospital (IT)
- Centre National de la Recherche Scientifique (FR)
- Christian-Albrechts-Universität zu Kiel (DE)
- University of Luxembourg (LU)
- Broad Institute (US)
- ORCID
- Suls, Arvid
- Weber, Yvonne
- Weckhuysen, Sarah
- Craiu, Dana C.
- Siekierska, Aleksandra
- Gormley, Padhraig
- Kluger, Gerhard
- Iliescu, Catrinel M.
- Serratosa, José
- Lemke, Johannes R.
- Hjalgrim, Helle
- Møller, Rikke S.
- Linnankivi, Tarja
- Dimova, Petia
- Striano, Pasquale
- Zara, Federico
- Marini, Carla
- Guerrini, Renzo
- Depienne, Christel
- Baulac, Stéphanie
- Kuhlenbäumer, Gregor
- Lehesjoki, Anna-Elina
- Palotie, Aarno
- Lerche, Holger
- Esguerra, Camila V.
- Helbig, Ingo
- Hendrickx, Rik
- Stephani, Ulrich
- Appenzeller, Silke
- Selmer, Kaja
- Brilstra, Eva
- Koeleman, Bobby
- Rosenow, Felix
- Arslan, Mutluay
- Yiş, Uluç
- Ivanović, Vanja
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 93
- Issue
- 5
- Pages
- 967-975
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC3824114
- OpenAlex
- W2069010410
- Cited by
- 219
- References
- 36
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 17 · 2023: 18 · 2022: 13 · 2021: 20 · 2020: 16 · 2019: 12 · 2018: 15 · 2017: 19 · 2016: 19 · 2015: 29 · 2014: 23
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- European Science Foundation
- Deutsche Forschungsgemeinschaft (Le1030/11-1)
- Academy of Finland (141549)
- Deutsche Gesellschaft für Epileptologie
- Folkhälsanin Tutkimussäätiö
- Vlaamse regering
- European Commission (261123)
- Sigrid Juséliuksen Säätiö
- Wellcome Trust (098051, 129680, 213506, 251704, WT089062)
- Universiteit Antwerpen
- Seventh Framework Programme (FP7/2007-2013, HEALTH-F4-2007- 201413)
- Fonds Wetenschappelijk Onderzoek
- Narodowe Centrum Nauki (800/N-ESF-EuroEPINOMICS/10/2011/0)
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- CHD2, Dravet syndrome, myoclonic epilepsy, haploinsufficiency, intellectual disability, epileptiform discharges, locomotor activity
- MeSH terms
- Animals, Child, Cognition Disorders, Seizures, Febrile, DNA-Binding Proteins, Epilepsies, Myoclonic, Female, Humans, Larva, Male, Intellectual Disability, Phenotype, Zebrafish, Cohort Studies, Gene Knockdown Techniques, Young Adult, Haploinsufficiency, Exome, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
